Pharmafile Logo
Pharmafocus logo
Advanced Search

Janssen

Showing 15 posts of 276 posts found.

Janssen reaches partial agreement over criminal investigation

August 10, 2011
Sales and Marketing Janssen, Risperdal, US, US Justice Department, illegal

Janssen Pharmaceuticals has reached a partial agreement with the US government over a criminal investigation into the marketing of Risperdal. …

News

Janssen to collaborate with Jubilant on neuroscience targets

June 29, 2011
Manufacturing and Production, Research and Development Janssen, Jubilant, neuroscience research

Janssen is to team up with Indian pharma services company Jubilant Life Sciences on neuroscience drug discovery. Jubilant Discovery Services …

News
GlaxoSmithKline

GSK takes lead role in UK personalised medicine programme

May 20, 2011
Research and Development AstraZeneca, GlaxoSmithKline, Ig Innovations, Janssen, Randox Laboratories, personalised medicine

The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …

News

Bayer-helmed oncology biomarker project launched

March 14, 2011
Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology

A project to develop the next generation of oncology biomarkers has been launched in Berlin. The pharma industry and European …

News

Janssen’s monthly antipsychotic approved in Europe

March 9, 2011
Sales and Marketing Janssen, Xeplion, antipsychotic, injectible antipsychotic, paliperidone palmitate, schizophrenia

Janssen’s injectable antipsychotic Xeplion has been approved by the European Commission for the treatment of schizophrenia. There is no cure …

News

Janssen’s Invega wins schizoaffective approval in Europe

January 6, 2011
Sales and Marketing Invega, Janssen, paliperidone ER, schizoaffective disorder, schizophrenia

Janssen’s Invega has become the first drug to be licensed in Europe to treat schizoaffective disorder. European regulators approved Invega …

News

Pharma manufacturing news in brief

December 21, 2010
Manufacturing and Production Airgas, Anthera Pharmaceuticals, Avid Bioservices, Berlin Packaging, Continental Packaging Solutions, Inno Biologics, Janssen, Merck BioManufacturing Network, Shandong Yanggu Zhongshi Pharmaceutical, SurModics

Our round-up of manufacturing updates includes a European recall for J&J, new contract manufacturing awards and facility updates from around …

News

New hepatitis C drug offers cure for more patients

December 17, 2010
Research and Development, Sales and Marketing HCV, Janssen, hepatitis C, liver disease, telaprevir

A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …

News
Blog footer

Digital Pharma: Facebook first from Janssen

October 8, 2010
Medical Communications Digital Pharma blog, Facebook, Janssen, Twitter, ipad, iphone, youtube

Janssen UK has officially launched its new psoriasis disease awareness campaign, part of which includes the first pharma Facebook page …

News

Janssen leads the pack at PM Society Digital Awards

October 6, 2010
Medical Communications Janssen, PM Society Digital Awards, disease awareness campaigns, pm society

Janssen was confirmed as one of the UK pharma industry’s most innovative pharma companies in the field of digital communications …

News

Caelyx rights to revert back to Janssen

September 30, 2010
Sales and Marketing Caelyx, Janssen, Merck

Marketing rights for cancer treatment Caeylx outside the US will be returned to Janssen from Merck after a licensing deal …

News
Janssen's psoriasis social media campaign

Digital Pharma: Janssen unveils UK social media plans

September 23, 2010
Medical Communications Digital Pharma blog, Facebook, Janssen, Twitter, psoriasis, social media, youtube

Janssen UK is to launch a wide-ranging social media campaign to raise awareness of the chronic skin condition psoriasis. The …

News
Blog footer

Digital Pharma: Byte-sized roundup

August 4, 2010
Medical Communications Digital Pharma blog, Janssen, disease awareness campaigns, iphone, social media

This week’s roundup includes Janssen-Cilag’s YouTube success, FDA to boost social media work, Novartis iPhone profile, Pfizer on SlideShare and …

News
Blog footer

Digital Pharma: First app for psoriasis launched

June 30, 2010
Medical Communications, Sales and Marketing Janssen, app, iphone, psoriasis

Janssen-Cilag UK has unveiled the first psoriasis iPhone app – a disease calculator for healthcare professionals treating the chronic skin condition. It …

News

Digital Pharma: The smokescreen of regulation

June 28, 2010
Medical Communications, Sales and Marketing Janssen, social media

When framing a story for the media it is well known in the communications community that a successful piece must …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025